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Abstract Using the Fura-2 method we investigated a possible 
direct action of testosterone on cytosolic free calcium of splenic T 
cells isolated from female C57BL/10 mice. Testosterone at 
physiological concentrations of 1-10 nM induces an increase in 
[Ca2+]i within seconds, which is due to Ca 2 + influx and not to 
Ca 2 + release from intracellular stores. In contrast, estradiol 
induces both Ca 2 + influx and Ca 2 + release. The testosterone-
induced Ca 2 + influx is mediated by Ni2+-blockable channels and 
is not inhibited by cyproterone, a blocker of the classical 
androgen receptor. Ca 2 + influx can also be induced by 
testosterone conjugated to BSA which is impermeable to the 
plasma membrane. These data indicate a novel mode of direct 
action of testosterone on T cells which is not mediated through 
the classical androgen receptor response, but through unconven-
tional plasma membrane receptors. 
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1. Introduction 
Testosterone is known to increase susceptibility to many 
infectious diseases including a wide variety of parasite infec-
tions [1,2], among these murine malaria [3,4]. At low circulat-
ing testosterone concentrations, C57BL/10 mice are normally 
resistant to Plasmodium chabaudi malaria, i.e. they are capable 
of self-healing blood stage infections of this parasite [3,5]. 
However, elevated serum testosterone concentrations cause a 
conversion from resistance to susceptibility, i.e. self-healing is 
prevented and the infections take a lethal course [3,5]. Con-
comitantly, splenic T cells change from a resistance-promoting 
phenotype to a susceptibility-mediating phenotype. These tes-
tosterone-induced functional changes in T cells become evi-
dent upon activation in response to P. chabaudi infections [6]. 
Androgens modulate gene expression by way of the classical 
nuclear androgen receptor (for reviews, see e.g. [7,8]). This is a 
protein of approximately 110 k D a and contains several do-
mains for androgen binding, transactivation, D N A binding, 
nuclear localization and dimerization (for reviews, see e.g. 
[7,9]). In addition to the classical androgen receptor, uncon-
ventional non-genomic cell surface receptors for testosterone 
have been recently described in typical testosterone target 
cells, i.e. rat osteoblasts [10]. These receptors belong to that 
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class of membrane receptors coupled to phospholipase C via a 
pertussis toxin-sensitive G-protein. Binding of testosterone to 
these surface receptors causes Ca 2 + influx and an increased 
formation of inositol 1,4,5-trisphosphate and diacylglycerol. 
The interactions of testosterone with T cells have remained 
elusive to date. Currently, the view predominates that testos-
terone is not able to act directly on T cells. The available 
information indicates that T cells do not contain classical 
androgen receptors (for reviews, see e.g. [1,2]). This study, 
however, provides first evidence that testosterone is able to 
act through non-genomic unconventional plasma membrane 
receptors, thus triggering Ca 2 + influx in activated T cells. 
2. Materials and methods 
2.1. Isolation of activated T cells 
Female mice of the inbred strain C57BL/10 aged 9-12 weeks were 
challenged with 106 P. chabaudi-'mfected erythrocytes for 7 days to 
activate splenic T cells. Spleens were aseptically removed and total 
nucleated spleen cells were isolated as detailed previously [6]. The 
activated T cells were then prepared using the nylon-wool procedure 
[11] resulting in 94% Thyl.2+ T cells as examined by FACScan anal-
ysis. 
2.2. Determination of [Ca2+]\ 
Isolated T cells were washed twice with 20 mM HEPES buffer (pH 
7.2) supplemented with 130 mM NaCl, 5 mM KC1, 1 mM CaCl2, 0.5 
mM MgCl2, 1 mM Na 2HP0 4 and 1 mg/ml glucose. Then, T cells (10
7/ 
ml) were loaded with 3 p,M Fura-2/acetoxymethylester (Amersham, 
Les Ulis, France) for 20 min in the same buffer at 37°C, diluted with 
7 ml of HEPES buffer, and reincubated for 20 min at 37°C. Cells were 
rapidly pelleted at 400 X g for 10 min and the pellet was resuspended 
in 2 ml of HEPES buffer. The Ca2+ measurements were performed 
with 1 ml of this cell suspension in a Hitachi F-2000 spectrofluorom-
eter at a constant temperature of 37°C. Reagents were added directly 
to the cuvette under continuous stirring. Testosterone, testosterone 3-
(0-carboxymethyl)oxime/BSA, estradiol and neomycin were from Sig-
ma (St. Quentin, Fallavier, France), cyproterone was kindly provided 
by Schering (Berlin, Germany). Hormones were dissolved in ethanol. 
The final concentration of ethanol in the cuvette was 0.01%, which 
never affected [Ca2+]j (cf. also [10]). The Fura-2 fluorescence was 
measured at 340 nm (calcium-bound Fura-2) and 380 nm (free 
Fura-2) for excitation and 510 nm for emission. The [Ca2+]i was 
computed from the ratio of 340/380 nm fluorescence values using 
the equation [Ca2+]i = Kd X (R-R^n)l(Rm^-R) X Sf380/Sb380 as pre-
viously described [12]. The dissociation constant for the Fura-2-Ca2+ 
complex was taken as 224 nM [12]. The values for Rm!a and Ämin were 
calculated from measurements using 25 u.M digitonin and 4 mM 
EGTA and enough Tris base to raise the pH to 8.3 or higher [10,12], 
3. Results 
Using the Fura-2 method, testosterone at the physiological 
concentration of 1 n M was found to induce an increase in 
[Ca2+]i of activated T cells (Fig. 1A). This increase was in 
the range between 10 and 25 n M Ca 2 + and occurred either 
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Fig. 1. Action of testosterone on cytosolic free calcium concentration in T cells. A: Direct effects of various physiological concentrations of tes-
tosterone; arrows indicate the addition of testosterone to the same T cell suspension. B: Effects of testosterone on T cells pretreated for 35 
min with 1 uM cyproterone, a nuclear androgen receptor blocker. C: Effects of testosterone 3-(0-carboxymethyl)oxime BSA (testosterone-
BSA), and BSA alone, as control, on intracellular calcium. 
as a spike or as a prolonged elevation of [Ca2+]j. Higher 
testosterone concentrations of 10 nM or 100 nM normally 
induced higher increases in [Ca2+], ranging between about 
10 and 60 nM or about 20 and 120 nM, respectively. A spike 
or prolonged elevation could be recorded up to about 40 nM 
Ca2+, while there was always a prolonged elevation at Ca2+ 
concentrations exceeding 50 nM. The reason why there is 
either a spike or a prolonged elevation is not yet known. 
Testosterone added to the same cell suspension for a second 
or third time induced additional increases in [Ca2+]i occurring 
always as a prolonged elevation (Fig. 1A). When T cells were 
first incubated with excess cyproterone, a blocker of the clas-
sical androgen receptor, before adding testosterone, the tes-
tosterone-induced increase in [Ca2+]i was not prevented (Fig. 
IB). Testosterone conjugated to BSA, which is impermeable 
for the plasma membrane, also induced an increase in [Ca2+]j 
in activated T cells, whereas BSA alone had absolutely no 
effect on [Ca2+]i (Fig. 1C). 
Possible sources of the testosterone-induced [Ca2+]j increase 
are the release of Ca2+ from intracellular Ca2+ stores and/or 
influx of extracellular Ca2+ through the plasma membrane. 
These possibilities were examined using three independent ap-
proaches, i.e. reducing the concentration of extracellular Ca2+ 
with EGTA, blocking the release of Ca2+ from intracellular 
stores through inhibition of phospholipase C via binding to 
phosphoinositides with neomycin [13], and attenuating Ca2+ 
influx with the Ca2+ channel inhibitor Ni2+ [14-16]. When 
extracellular Ca2+ was removed by EGTA, testosterone in-
duced only - if at all - a very small release of Ca2+ from 
intracellular Ca2+ stores, even if the testosterone concentra-
tion was as high as 10 uM (Fig. 2A). Blockade of phospho-
lipase C by neomycin did not prevent the testosterone-induced 
rise in [Ca2+]i (Fig. 2B). These data indicate that the testos-
terone-induced increase in [Ca2+]j does not result from a re-
lease of Ca2+ from intracellular Ca2+ stores, such as the en-
doplasmic reticulum, but rather signals influx of extracellular 
Ca2+ into cells. This influx is not due to diffusion, but is 
channel-mediated. The specific Ca2+ channel blocker Ni2+ in-
hibited the testosterone-induced Ca2+ influx (Fig. 2C). 
Further evidence for the specificity of the testosterone effect 
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Fig. 2. Effects of different substances on intracellular calcium response to testosterone. A: T cells were incubated for 1 min with 3 mM EGTA, 
an extracellular Ca2+ chelator, before adding 10 |iM testosterone. B: T cells were incubated for 3 min with 1 mM neomycin, an indirect inhibi-
tor of phospholipase C via binding to phosphoinositides, before adding 10 nM testosterone. C: T cells were incubated for 5 min with various 
concentrations of Ni2+, a specific Ca2+ channel blocker, before adding 1 uM testosterone. 
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Fig. 3. Action of 17ß-estradiol on cytosolic free calcium concentration in T cells. A: Direct effect of estradiol on T cells incubated or not for 
3 min with 1 mM neomycin, an indirect inhibitor of phospholipase C before adding 10 nM estradiol. B: T cells were incubated with 2 mM 
EGTA for 1 min before adding 10 nM estradiol. 
was obtained by testing the effect of estradiol on [Ca2+]i of 
activated T cells. Estradiol also caused an increase in [Ca2+]; 
as shown in Fig. 3A. However, this effect differed from the 
testosterone effect, since estradiol caused both Ca2+ influx and 
release from intracellular Ca2+ stores (Fig. 3A,B). When all 
the extracellular Ca2+ was complexed by EGTA, estradiol still 
induced a rise in [Ca2+]i due to Ca2+ release from intracellular 
stores. This rise was about 10 nM at both 0.1 nM and 10 nM 
estradiol, and could be increased to 22 nM Ca2+ by 10 (i.M 
estradiol, in contrast to 10 uM testosterone (Fig. 2A). 
The testosterone-induced changes in [Ca2+]; obviously have 
consequences for the responsiveness of T cells to antigenic 
stimulation. When T cells were stimulated in vitro using the 
monoclonal anti-CD3 antibody 145-2011 (Pharmingen, San 
Diego, CA, USA) directed to the 25 kDa e chain of the T 
cell receptor-associated CD3 complex, there was a rise in 
[Ca2+]j, and after reaching the maximum, [Ca2+]; declined 
somewhat before reaching a plateau as illustrated in Fig. 
4A, in accordance with previous findings (see e.g. [14]). Incu-
bation of T cells with testosterone induced a small transient 
increase in [Ca2+]i, and the subsequent activation by anti-CD3 
was perturbed (Fig. 4B). This became evident as an impaired 
increase in [Ca2+];, lower maximal levels of [Ca2+];, and an 
elevated sustained [Ca2+]j plateau, when compared to T cell 
activation without testosterone. Fig. 4C shows that testoster-
one is still able to evoke an increase of [Ca2+]i after anti-CD3 
stimulation of T cells. 
4. Discussion 
This study provides first evidence for a direct, specific effect 
of testosterone on activated T cells. This direct effect is not 
mediated through the classical nuclear androgen receptor re-
sponse, but obviously through unconventional non-genomic 
surface testosterone receptors. This is in accordance with pre-
vious studies which have been unable to detect classical an-
drogen receptors in T cells [1,17-21]. The direct effect of tes-
tosterone on T cells in vitro manifests itself as an increase in 
[Ca2+];. This increase is due to an influx of Ca2+ and can be 
induced even at concentrations as low as 1 nM. The Ca2+ 
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Fig. 4. Effects of testosterone and anti-CD3 on cytosolic free calcium concentration in T cells. A: Direct effect of 15 ug/ml anti-CD3. B: Effect 
of 15 ug/ml anti-CD3 on T cells pretreated with 10 nM testosterone for 2 min. C: Effect of 10 nM testosterone on T cells stimulated with 15 
ug/ml anti-CD3 for 3 min. 
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influx is specific, i.e. it is not a simple diffusion phenomenon, 
but rather it is mediated by Ni2+-blockable Ca2+ channels 
[14—16]. Moreover, the Ca2+ influx cannot be inhibited by 
classical androgen receptor blockers such as cyproterone. It 
is noteworthy that this Ca2+ influx is also inducible by testos-
terone conjugated to BSA, which is not permeable to the 
plasma membrane. This indicates that testosterone binds to 
unconventional non-genomic surface testosterone receptors 
and, thus, triggers an opening of Ca2+ channels in the plasma 
membrane. However, the mechanisms of the testosterone-in-
duced increase of [Ca2+]; in T cells are not identical to those 
recently identified in rat osteoblasts [10]. In the latter, the 
binding of testosterone to membrane-bound androgen recep-
tors induces not only a Ca2+ influx, but also a Ca2+ release 
from intracellular stores via the inositol 1,4,5-trisphosphate 
pathway. Such a release from intracellular stores is obviously 
not inducible in T cells by testosterone, though activated T 
cells contain such Ca2+ stores which release Ca2+ upon in-
duction by estradiol (cf. also [22,23]). In accordance with our 
findings, it has been recently shown that the channel-mediated 
Ca2+ influx in murine T cells is not necessarily coupled with 
an inositol 1,4,5-trisphosphate-mediated Ca2+ release from 
intracellular stores [14,24]. Moreover, our data demonstrate 
that testosterone is able to affect directly the responsiveness of 
T cells to antigenic stimulation. Thus, in vitro activation of T 
cells by anti-CD3, at least the initial events associated with the 
increase in [Ca2+];, is perturbed by testosterone. This effect of 
testosterone is not due to testosterone binding per se or to 
competition of testosterone with anti-CD3 binding sites on the 
T cell surface since, after T cells have been activated by anti-
CD3, testosterone can still cause an increase in [Ca2+];. 
Previously, we have shown that in vivo testosterone induces 
functional changes in splenic T cells which acquire the capa-
bility to confer the testosterone-induced susceptibility to P. 
chabaudi malaria [6]. The present data suggest that the basi-
cally initial event for these functional changes is the binding of 
testosterone to unconventional surface receptors to T cells 
triggering Ca2+ influx. It may therefore essentially contribute 
to those mechanisms mediating testosterone-induced suscept-
ibility to P. chabaudi malaria, which has been previously 
found to be also not mediated through the classical androgen 
receptor response [25,26]. 
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